Medical boards change or consider amending mental health-related licensing questionsSeptember 30, 2019Business of Medicine
Second-generation anti-BCMA CAR T-cell therapy shows promise in myeloma trialSeptember 27, 2019Multiple Myeloma
Patient-reported outcomes are here to staySeptember 27, 2019Business of MedicinePatient & Survivor Care
German CLLM1 study: 4-year data raise concerns about lenalidomide maintenanceSeptember 27, 2019CLLB Cell Lymphoma
Cancer drug prices higher in U.S. than Europe; don’t correlate with clinical benefitSeptember 27, 2019Business of Medicine
Daratumumab approved in combo with VTd for transplant-eligible multiple myelomaSeptember 26, 2019Multiple MyelomaTransplant